1. Home
  2. IMRN vs BRN Comparison

IMRN vs BRN Comparison

Compare IMRN & BRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immuron Limited

IMRN

Immuron Limited

HOLD

Current Price

$1.06

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Logo Barnwell Industries Inc.

BRN

Barnwell Industries Inc.

HOLD

Current Price

$1.14

Market Cap

13.8M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMRN
BRN
Founded
1994
1956
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
12.0M
13.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IMRN
BRN
Price
$1.06
$1.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
82.5K
121.6K
Earning Date
02-27-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,777,422.00
$13,697,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
48.63
N/A
52 Week Low
$0.68
$1.05
52 Week High
$2.39
$2.28

Technical Indicators

Market Signals
Indicator
IMRN
BRN
Relative Strength Index (RSI) 51.30 52.68
Support Level $1.01 $1.08
Resistance Level $1.25 $1.40
Average True Range (ATR) 0.10 0.08
MACD 0.06 0.00
Stochastic Oscillator 68.42 21.87

Price Performance

Historical Comparison
IMRN
BRN

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

About BRN Barnwell Industries Inc.

Barnwell Industries Inc is an oil and gas company engaged in the acquisition, development, production, and sale of crude oil and natural gas. The Company operates through two segments: the Oil and Natural Gas segment, which focuses on oil and natural gas development, production, acquisitions, and sales in the United States and Canada; and the Land Investment segment, which owns leasehold land interests in Hawaii. The Company generates the majority of its revenue from the Oil and Natural Gas segment. The company operates in two geographic regions, the United States and Canada, with Canada contributing the majority of revenue.

Share on Social Networks: